COMP <GO>
ABVX vs ALKS // RSI-14 & 200D SMA MOMENTUM
Abivax SA (NASDAQ) VS. Alkermes plc (NASDAQ) • 15-METRIC TALLY: ABVX 3
— ALKS 8
▲ RSI-14 & 200D SMA MOMENTUM LEADER: ALKS
LAST: $84.91 (-1.94%) • MKT CAP: $7.56B
rsi-technicals
41.0
LAST: $44.89 (-0.99%) • MKT CAP: $7.61B
rsi-technicals
61.0
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ABVX VS. ALKS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ABVX | ALKS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 86.70% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 14.00% | -4.10 | ALKS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | 25.1x | -4.10 | ABVX | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 6.31% | -4.10 | ALKS | /fcf-yield <GO> |
| Operating Margin | 13.90% | 17.20% | -3.30 | ALKS | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 16.40% | -5.50 | ALKS | /net-margins <GO> |
| Revenue Growth (YoY) | 8.80% | -5.20% | +14.00 | ABVX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 8.03 | -4.29 | ALKS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ABVX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 41.0 | 61.0 | -20.00 | ALKS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 1.05 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.5x | 29.3x | +1.20 | ALKS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.56B | $7.61B | -$51.1M | ALKS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ABVX REV | ALKS REV | ABVX GROSS % | ALKS GROSS % | ABVX FCF | ALKS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $1.48B | — | 86.7% | — | $480.3M |
| FY 2024 | — | $1.56B | — | 84.2% | — | $405.6M |
| FY 2023 | — | $1.66B | — | — | — | $326.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ABVX // BETA 1.05
ALKS // BETA 1.05